Anhui Huaren Health Pharmaceutical Co., Ltd. (SHE:301408)
China flag China · Delayed Price · Currency is CNY
12.76
-0.39 (-2.97%)
Nov 17, 2026, 4:00 PM EST

SHE:301408 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
5,8005,3784,4543,7233,2022,269
Other Revenue
109.13109.1377.8174.4260.7469.46
5,9095,4874,5323,7973,2622,339
Revenue Growth
14.63%21.07%19.34%16.39%39.50%21.12%
Cost of Revenue
3,8683,6373,0662,6422,2051,526
Gross Profit
2,0411,8501,4661,1551,057812.4
Selling, General & Admin
1,5041,4041,190961.8807.26687.3
Research & Development
28.4529.5829.3924.194.170.5
Other Operating Expenses
22.9516.528.695.6617.1613.02
Operating Expenses
1,5661,4651,228993.91829.62705.21
Operating Income
474.52384.69237.65161.47227.66107.19
Interest Expense
-31.97-30.22-32.15-29.05-23.38-24.03
Interest & Investment Income
12.8915.0617.1814.845.092.77
Currency Exchange Gain (Loss)
-0.13-0.130.110.1--
Other Non Operating Income (Expenses)
-6.11-6.75-9.29-6.79-7.74-2.73
EBT Excluding Unusual Items
449.2362.64213.49140.56201.6383.21
Impairment of Goodwill
-72.11-72.11-17.2---
Gain (Loss) on Sale of Investments
---0.03--
Gain (Loss) on Sale of Assets
2.973.742.721.040.610.19
Asset Writedown
5.12-0.04-0.010-0.01-0.02
Other Unusual Items
-2.380.176.479.8712.5110.84
Pretax Income
382.8294.39205.47151.51214.7494.22
Income Tax Expense
107.780.5253.2133.8354.4824.48
Earnings From Continuing Operations
275.1213.87152.26117.68160.2669.73
Minority Interest in Earnings
-24.93-22.51-14.56-3.010.52-0.01
Net Income
250.17191.35137.7114.67160.7869.73
Net Income to Common
250.17191.35137.7114.67160.7869.73
Net Income Growth
34.14%38.96%20.09%-28.68%130.58%-21.58%
Shares Outstanding (Basic)
399399405395342332
Shares Outstanding (Diluted)
399399405395342332
Shares Change
-1.56%-1.57%2.43%15.59%3.02%-2.92%
EPS (Basic)
0.630.480.340.290.470.21
EPS (Diluted)
0.630.480.340.290.470.21
EPS Growth
36.27%41.18%17.24%-38.30%123.81%-19.23%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
750.95681.76408.33-89.6469.07106.91
Free Cash Flow Per Share
1.881.711.01-0.230.200.32
Dividend Per Share
0.1000.1000.1000.100--
Dividend Growth
0%0%0%---
Gross Margin
34.53%33.71%32.34%30.43%32.41%34.74%
Operating Margin
8.03%7.01%5.24%4.25%6.98%4.58%
Profit Margin
4.23%3.49%3.04%3.02%4.93%2.98%
Free Cash Flow Margin
12.71%12.43%9.01%-2.36%2.12%4.57%
EBITDA
521.99429.03277.81182.91240.37267.85
EBITDA Margin
8.83%7.82%6.13%4.82%7.37%11.45%
D&A For EBITDA
47.4744.3440.1721.4512.71160.66
EBIT
474.52384.69237.65161.47227.66107.19
EBIT Margin
8.03%7.01%5.24%4.25%6.98%4.58%
Effective Tax Rate
28.13%27.35%25.90%22.33%25.37%25.99%
Revenue as Reported
5,9095,4874,5323,7973,2622,339
Advertising Expenses
-37.3725.1921.3617.995.27